These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20812144)

  • 1. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery.
    Acuner Ozbabacan SE; Gursoy A; Keskin O; Nussinov R
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):527-37. PubMed ID: 20812144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot spots in protein-protein interfaces: towards drug discovery.
    Cukuroglu E; Engin HB; Gursoy A; Keskin O
    Prog Biophys Mol Biol; 2014; 116(2-3):165-73. PubMed ID: 24997383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Druggable orthosteric and allosteric hot spots to target protein-protein interactions.
    Ma B; Nussinov R
    Curr Pharm Des; 2014; 20(8):1293-301. PubMed ID: 23713780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational allosteric ligand binding site identification on Ras proteins.
    McCarthy M; Prakash P; Gorfe AA
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):3-10. PubMed ID: 26487442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allosteric switch and conformational states in Ras GTPase affected by small molecules.
    Johnson CW; Mattos C
    Enzymes; 2013; 33 Pt A():41-67. PubMed ID: 25033800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
    Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
    J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of small molecule inhibitors of protein-protein interactions using combined ligand and target score normalization.
    Casey FP; Pihan E; Shields DC
    J Chem Inf Model; 2009 Dec; 49(12):2708-17. PubMed ID: 19994847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Protein Communication to Drug Discovery.
    Persico M; Di Dato A; Orteca N; Fattorusso C; Novellino E; Andreoli M; Ferlini C
    Curr Top Med Chem; 2015; 15(20):2019-31. PubMed ID: 25986690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner.
    Fry DC
    Curr Pharm Des; 2012; 18(30):4679-84. PubMed ID: 22650256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapping moving targets with small molecules.
    Lee GM; Craik CS
    Science; 2009 Apr; 324(5924):213-5. PubMed ID: 19359579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein binding site analysis for drug discovery using a computational fragment-based method.
    Ludington JL
    Methods Mol Biol; 2015; 1289():145-54. PubMed ID: 25709039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free screening of drug-protein interactions by time-resolved Fourier transform infrared spectroscopic assays exemplified by Ras interactions.
    Kötting C; Suveyzdis Y; Bojja RS; Metzler-Nolte N; Gerwert K
    Appl Spectrosc; 2010 Sep; 64(9):967-72. PubMed ID: 20828432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragments and hot spots in drug discovery.
    Vajda S; Whitty A; Kozakov D
    Oncotarget; 2015 Aug; 6(22):18740-1. PubMed ID: 26300051
    [No Abstract]   [Full Text] [Related]  

  • 18. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knitting and untying the protein network: modulation of protein ensembles as a therapeutic strategy.
    Gordo S; Giralt E
    Protein Sci; 2009 Mar; 18(3):481-93. PubMed ID: 19241367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is allostery an intrinsic property of all dynamic proteins?
    Gunasekaran K; Ma B; Nussinov R
    Proteins; 2004 Nov; 57(3):433-43. PubMed ID: 15382234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.